A new share issue in Umeå-based Lipigon Pharmaceuticals that was issued ahead of a listing on the Nasdaq First North Growth Market has exceeded all expectations. The listing was oversubscribed by 479 per cent, raising SEK 235 million spread over more than 9,000 investors.
From March 1st Västerbotten will become the first region in Sweden to offer its residents home testing kits that can detect antibodies for COVID-19.
Umeå-based biopharmaceutical company Lipum AB is raising capital for a listing on the Nasdaq First North Growth Market in the spring of 2021. “We are taking the next exciting step in the company's development”, says Lipum’s CEO Einar Pontén.
Lipum AB has appointed Marina Norberg Chief Financial Officer (CFO).
Umeå technology companies back young enterprise initiative to get more women into tech industry Three high school girls from Umeå have started a UF (Young Enterprise) company that hopes to encourage more girls to study technology and qualify to work in the tech industry.
Umeå-based biotech company QureTech Bio has appointed Helén Fält as its new acting CEO, replacing Fredrik Almqvist, one of the company’s original founders. “We have recently secured significant new investment and so it feels like the perfect time for Helén to come in and develop our business even further,” says Fredrik Almqvist.
Lipigon Pharmaceuticals AB, which develops new treatments for lipid-related diseases, announces that the board has elected Urban Paulsson as the new chairman of the board. Paulsson was elected to the board on October 30, 2020 and now replaces Carina Schmidt, who requested her own resignation from the board.
Inficure Bio, based in Umeå in northern Sweden, has recently been granted a patent in the United States for its unique preclinical model. At the same time a study describing the basics of the model has been accepted for publication in respected online journal Scientific Reports.
A new AI solution for sustainable production is to be tested at Diamyd Medical's vaccine manufacturing facility in Umeå. It is hoped, once the solution has been refined, that it can be introduced in companies throughout Sweden.
Umeå Biotech Incubator (UBI) has strengthened its board with the appointment of respected business profiles Anette Nordvall, named Sweden's most powerful tech investor by DI Digital, and Camilla Huse Bondesson, who has extensive experience of marketing, sales and business development in the life science industry.
At an Extraordinary General Meeting, Urban Paulsson was elected a regular board member of Umeå-based Lipigon Pharmaceuticals AB. Urban Paulsson's business law expertise entails a strengthening of the Board and is an important component for the company's continued successful development.
Umeå-based life science company Inficure Bio is one of three companies from northern Sweden chosen to present their business cases at ‘Mötesplats Stockholm – The Great Northern Capital Connect’ in early 2021.
Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.
Tvistevägen 48C
907 36 Umeå
Sweden